[Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020].
N Yu PshenichnayaE N KarevaIrina A LenevaVilya A BulgakovaI E KravchenkoI V NikolaevaA I GrekovaA P IvanovaL V PuzyrevaG M KhasanovaS N OrlovaE P TihonovaV A PetrovOleg V MalininN V KolaevaE V VolchkovaN N KanshinaVladimir P ChulanovPublished in: Terapevticheskii arkhiv (2021)
Umifenovir therapy and inclusion of interferon in AVT regimens was associated improvement in the clinical manifestation of the disease among patients.